CD274 and neoplasm: Here, we present a novel mechanism whereby ATO improves EV PD-L1-mediated immunosuppression; in addition, our results provide evidence that ATO-induced antitumor immune responses can be regulated through the inhibition of co-inhibitory receptors owing to T-cell activity and can be correlated with inhibition of tumor-derived EV PD-L1.